Form 8-K - Current report:
SEC Accession No. 0000950170-24-113271
Filing Date
2024-10-07
Accepted
2024-10-07 16:45:40
Documents
11
Period of Report
2024-10-07
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K bior-20241007.htm   iXBRL 8-K 60565
  Complete submission text file 0000950170-24-113271.txt   186904

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bior-20241007.xsd EX-101.SCH 31517
13 EXTRACTED XBRL INSTANCE DOCUMENT bior-20241007_htm.xml XML 4898
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 241358316
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)